LPL Financial’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$55.6K Sell
45,967
-2,200
-5% -$3.01K ﹤0.01% 6109
2026
Q2
$67.4K Sell
48,167
-72,629
-60% -$119K ﹤0.01% 5987
2026
Q1
$204K Buy
120,796
+22,255
+23% +$39.5K ﹤0.01% 5481
2025
Q4
$140K Sell
98,541
-120,600
-55% -$176K ﹤0.01% 5541
2025
Q3
$359K Buy
219,141
+17,302
+9% +$19.2K ﹤0.01% 4900
2025
Q2
$148K Buy
201,839
+135,620
+205% +$117K ﹤0.01% 5178
2025
Q1
$53.4K Buy
66,219
+1,454
+2% +$1.67K ﹤0.01% 5148
2024
Q4
$89.4K Sell
64,765
-29,321
-31% -$32.9K ﹤0.01% 5013
2024
Q3
$97.8K Sell
94,086
-24,400
-21% -$33.5K ﹤0.01% 4895
2024
Q2
$205K Buy
118,486
+5,750
+5% +$11.6K ﹤0.01% 4552
2024
Q1
$269K Buy
112,736
+57,702
+105% +$142K ﹤0.01% 4289
2023
Q4
$183K Buy
+55,034
New +$147K ﹤0.01% 4415

Other funds holding CHRS

LPL Financial's CHRS Position: Q3 2026 in Review

LPL Financial reduced its Coherus Oncology (CHRS) stake by 4.6% in Q3 2026, selling an estimated $3.01K and leaving 45,967 shares worth $55.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6109.

LPL Financial first reported a position in CHRS in Q4 2023 and has held it in 12 quarters since. The position peaked at $359K in Q3 2025. 135 funds tracked by Wall St. Rank hold CHRS as of Q3 2026.

  • LPL Financial held 45,967 shares of Coherus Oncology worth $55.6K as of Q3 2026.
  • LPL Financial sold 2,200 Coherus Oncology shares in Q3 2026, an estimated $3.01K.
  • Coherus Oncology made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #6109 holding.
  • LPL Financial first reported a position in Coherus Oncology in Q4 2023 and has held it in 12 quarters since.
  • LPL Financial's Coherus Oncology position peaked at $359K in Q3 2025.
  • 135 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.